Use of FRAX as a Determinant for Risk-Based Osteoporosis Screening May Decrease Unnecessary Testing While Improving the Odds of Identifying Treatment Candidates

Frederick D. Edwards, Michael L. Grover, Curtiss B. Cook, Yu Hui H Chang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: We have assessed the hypothetical impact of guideline-concordant osteoporosis screening on baseline behaviors utilizing two different guidelines and determined the relative ability of each to identify osteoporosis treatment candidates. Methods: We conducted secondary analyses from the Fracture Risk Perception Study, which enrolled patients aged 50 to 75years to complete questionnaires about their bone health. We determined our baseline screening rates and detection of treatment candidates and then assessed the hypothetical impact of adherence to U.S. Preventive Services Task Force (USPSTF) and National Osteoporosis Foundation (NOF) criteria, particularly for women aged 50 to64. Results: Of 144 women aged 50 to 64years screened, 14 (9.7%) were treatment candidates. Screening based on identification of one or more risks (NOF) would lead to testing of 102 of the 144 patients (71%) to identify 12 of 14 treatment candidates (86%). Applying USPSTF criteria (9.3% FRAX threshold) would test 45 of the same 144 women (31%) to identify 11 of 14 treatment candidates (79%). NOF risk-based criteria would result in a moderate absolute screening rate reduction (16%, p=.0011; 95% CI, 7%-25%), but only marginal improvement in identifying treatment candidates (odds ratio, 2.67; 95% CI,0.57-12.47). Applying the more selective USPSTF criteria greatly reduced unnecessary testing (56% absolute screening rate reduction; p<.0001; 95% CI, 47%-64%) while further improving the odds of identifying treatment candidates (odds ratio, 10.35; 95% CI,2.72-39.35). Conclusions: When contemplating screening younger patients, systematic calculation of FRAX and ordering only when the 9.3% fracture risk threshold is reached may decrease unnecessary screening for many women while still identifying appropriate osteoporosis treatment candidates.

Original languageEnglish (US)
Pages (from-to)629-634
Number of pages6
JournalWomen's Health Issues
Volume24
Issue number6
DOIs
StatePublished - Nov 1 2014

Fingerprint

bone disease
Osteoporosis
candidacy
determinants
Advisory Committees
Therapeutics
Odds Ratio
Guidelines
Aptitude
Bone and Bones
questionnaire
Health
ability
health

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Public Health, Environmental and Occupational Health
  • Maternity and Midwifery
  • Health(social science)

Cite this

Use of FRAX as a Determinant for Risk-Based Osteoporosis Screening May Decrease Unnecessary Testing While Improving the Odds of Identifying Treatment Candidates. / Edwards, Frederick D.; Grover, Michael L.; Cook, Curtiss B.; Chang, Yu Hui H.

In: Women's Health Issues, Vol. 24, No. 6, 01.11.2014, p. 629-634.

Research output: Contribution to journalArticle

Edwards, Frederick D. ; Grover, Michael L. ; Cook, Curtiss B. ; Chang, Yu Hui H. / Use of FRAX as a Determinant for Risk-Based Osteoporosis Screening May Decrease Unnecessary Testing While Improving the Odds of Identifying Treatment Candidates. In: Women's Health Issues. 2014 ; Vol. 24, No. 6. pp. 629-634.
@article{034184b60d594d0eb20c7758d758519f,
title = "Use of FRAX as a Determinant for Risk-Based Osteoporosis Screening May Decrease Unnecessary Testing While Improving the Odds of Identifying Treatment Candidates",
abstract = "Purpose: We have assessed the hypothetical impact of guideline-concordant osteoporosis screening on baseline behaviors utilizing two different guidelines and determined the relative ability of each to identify osteoporosis treatment candidates. Methods: We conducted secondary analyses from the Fracture Risk Perception Study, which enrolled patients aged 50 to 75years to complete questionnaires about their bone health. We determined our baseline screening rates and detection of treatment candidates and then assessed the hypothetical impact of adherence to U.S. Preventive Services Task Force (USPSTF) and National Osteoporosis Foundation (NOF) criteria, particularly for women aged 50 to64. Results: Of 144 women aged 50 to 64years screened, 14 (9.7{\%}) were treatment candidates. Screening based on identification of one or more risks (NOF) would lead to testing of 102 of the 144 patients (71{\%}) to identify 12 of 14 treatment candidates (86{\%}). Applying USPSTF criteria (9.3{\%} FRAX threshold) would test 45 of the same 144 women (31{\%}) to identify 11 of 14 treatment candidates (79{\%}). NOF risk-based criteria would result in a moderate absolute screening rate reduction (16{\%}, p=.0011; 95{\%} CI, 7{\%}-25{\%}), but only marginal improvement in identifying treatment candidates (odds ratio, 2.67; 95{\%} CI,0.57-12.47). Applying the more selective USPSTF criteria greatly reduced unnecessary testing (56{\%} absolute screening rate reduction; p<.0001; 95{\%} CI, 47{\%}-64{\%}) while further improving the odds of identifying treatment candidates (odds ratio, 10.35; 95{\%} CI,2.72-39.35). Conclusions: When contemplating screening younger patients, systematic calculation of FRAX and ordering only when the 9.3{\%} fracture risk threshold is reached may decrease unnecessary screening for many women while still identifying appropriate osteoporosis treatment candidates.",
author = "Edwards, {Frederick D.} and Grover, {Michael L.} and Cook, {Curtiss B.} and Chang, {Yu Hui H}",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.whi.2014.06.006",
language = "English (US)",
volume = "24",
pages = "629--634",
journal = "Women's Health Issues",
issn = "1049-3867",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Use of FRAX as a Determinant for Risk-Based Osteoporosis Screening May Decrease Unnecessary Testing While Improving the Odds of Identifying Treatment Candidates

AU - Edwards, Frederick D.

AU - Grover, Michael L.

AU - Cook, Curtiss B.

AU - Chang, Yu Hui H

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Purpose: We have assessed the hypothetical impact of guideline-concordant osteoporosis screening on baseline behaviors utilizing two different guidelines and determined the relative ability of each to identify osteoporosis treatment candidates. Methods: We conducted secondary analyses from the Fracture Risk Perception Study, which enrolled patients aged 50 to 75years to complete questionnaires about their bone health. We determined our baseline screening rates and detection of treatment candidates and then assessed the hypothetical impact of adherence to U.S. Preventive Services Task Force (USPSTF) and National Osteoporosis Foundation (NOF) criteria, particularly for women aged 50 to64. Results: Of 144 women aged 50 to 64years screened, 14 (9.7%) were treatment candidates. Screening based on identification of one or more risks (NOF) would lead to testing of 102 of the 144 patients (71%) to identify 12 of 14 treatment candidates (86%). Applying USPSTF criteria (9.3% FRAX threshold) would test 45 of the same 144 women (31%) to identify 11 of 14 treatment candidates (79%). NOF risk-based criteria would result in a moderate absolute screening rate reduction (16%, p=.0011; 95% CI, 7%-25%), but only marginal improvement in identifying treatment candidates (odds ratio, 2.67; 95% CI,0.57-12.47). Applying the more selective USPSTF criteria greatly reduced unnecessary testing (56% absolute screening rate reduction; p<.0001; 95% CI, 47%-64%) while further improving the odds of identifying treatment candidates (odds ratio, 10.35; 95% CI,2.72-39.35). Conclusions: When contemplating screening younger patients, systematic calculation of FRAX and ordering only when the 9.3% fracture risk threshold is reached may decrease unnecessary screening for many women while still identifying appropriate osteoporosis treatment candidates.

AB - Purpose: We have assessed the hypothetical impact of guideline-concordant osteoporosis screening on baseline behaviors utilizing two different guidelines and determined the relative ability of each to identify osteoporosis treatment candidates. Methods: We conducted secondary analyses from the Fracture Risk Perception Study, which enrolled patients aged 50 to 75years to complete questionnaires about their bone health. We determined our baseline screening rates and detection of treatment candidates and then assessed the hypothetical impact of adherence to U.S. Preventive Services Task Force (USPSTF) and National Osteoporosis Foundation (NOF) criteria, particularly for women aged 50 to64. Results: Of 144 women aged 50 to 64years screened, 14 (9.7%) were treatment candidates. Screening based on identification of one or more risks (NOF) would lead to testing of 102 of the 144 patients (71%) to identify 12 of 14 treatment candidates (86%). Applying USPSTF criteria (9.3% FRAX threshold) would test 45 of the same 144 women (31%) to identify 11 of 14 treatment candidates (79%). NOF risk-based criteria would result in a moderate absolute screening rate reduction (16%, p=.0011; 95% CI, 7%-25%), but only marginal improvement in identifying treatment candidates (odds ratio, 2.67; 95% CI,0.57-12.47). Applying the more selective USPSTF criteria greatly reduced unnecessary testing (56% absolute screening rate reduction; p<.0001; 95% CI, 47%-64%) while further improving the odds of identifying treatment candidates (odds ratio, 10.35; 95% CI,2.72-39.35). Conclusions: When contemplating screening younger patients, systematic calculation of FRAX and ordering only when the 9.3% fracture risk threshold is reached may decrease unnecessary screening for many women while still identifying appropriate osteoporosis treatment candidates.

UR - http://www.scopus.com/inward/record.url?scp=84909961934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909961934&partnerID=8YFLogxK

U2 - 10.1016/j.whi.2014.06.006

DO - 10.1016/j.whi.2014.06.006

M3 - Article

C2 - 25128036

AN - SCOPUS:84909961934

VL - 24

SP - 629

EP - 634

JO - Women's Health Issues

JF - Women's Health Issues

SN - 1049-3867

IS - 6

ER -